APA (7th ed.) Citation

AC, P., S, M., U, M., R, M., U, S., S, C., & JF, D. (2014). Everolimus is a potent inhibitor of activated hepatic stellate cell functions in vitro and in vivo, while demonstrating anti-angiogenic activities. Clinical science (London, England : 1979), 126(11), 775. https://doi.org/10.1042/CS20130081

Chicago Style (17th ed.) Citation

AC, Piguet, Majumder S, Maheshwari U, Manjunathan R, Saran U, Chatterjee S, and Dufour JF. "Everolimus Is a Potent Inhibitor of Activated Hepatic Stellate Cell Functions in Vitro and in Vivo, While Demonstrating Anti-angiogenic Activities." Clinical Science (London, England : 1979) 126, no. 11 (2014): 775. https://doi.org/10.1042/CS20130081.

MLA (9th ed.) Citation

AC, Piguet, et al. "Everolimus Is a Potent Inhibitor of Activated Hepatic Stellate Cell Functions in Vitro and in Vivo, While Demonstrating Anti-angiogenic Activities." Clinical Science (London, England : 1979), vol. 126, no. 11, 2014, p. 775, https://doi.org/10.1042/CS20130081.